Close this search box.

Sensus Healthcare, Inc. Names Anthony Petrelli to its Board of Directors

August 2, 2016
– Over 40 Years in Investment Banking
– Extensive Regulatory and Securities Advisory Experience

BOCA RATON, Fla., Aug. 2, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy, today announced the appointment of Anthony (“Tony”) Petrelli to its Board of Directors. Mr. Petrelli is President, Chairman of the Board and Director of Investment Banking of Neidiger, Tucker, Bruner, Inc. (“NTB”), a SEC-registered broker-dealer firm.

Joe Sardano, Chief Executive Officer for Sensus Healthcare, noted, “It is an honor to appoint Tony to our Board of Directors. For years, Tony has served as a thoughtful resource to Sensus, helping us navigate the capital markets and achieve numerous operational goals, which culminated in our successful initial public offering in June. We are pleased that Tony has graciously accepted our invitation and look forward to his continued contributions and extensive capital markets expertise as we scale our operations and grow our company.”

Commenting on his appointment, Mr. Petrelli stated, “I am thrilled to officially join Sensus Healthcare as a member of its board. My dedication and passion for Sensus is unwavering. Sensus Healthcare’s innovative technology for treating skin cancer and keloids with a non-invasive solution is just the beginning of what I believe this team can accomplish. I will be pleased to serve as a resource as we grow the Company over the long-term.”

Mr. Petrelli has over 40 years of experience in the investment banking industry. Prior to joining NTB, he served as Executive Vice President and Managing Director of Corporate Finance for Hanifen, Imhoff, Inc. and Vice President of Corporate Finance for Bosworth, Sullivan & Co. Mr. Petrelli is a member of the Board of Directors of Ring Energy, Inc. and owner of Equinox Counseling LLC. He has also served on numerous regulatory and securities industry committees including the FINRA Corporate Finance and Fixed Income Committees, the NASD Small Firm Advisory Board and as Chairman of the FINRA District Business Conduct Committee, District 3.

Mr. Petrelli received his Bachelors of Science in Business (Finance) and his Masters of Business Administration (MBA) from the University of Colorado and a Masters of Arts in Counseling from Denver Seminary.

About Sensus
Sensus Healthcare, Inc. is a medical device company that is committed to enabling non-invasive and cost-effective treatment of non-melanoma skin cancers and keloids. Sensus uses a proprietary low energy x-ray radiation technology known as superficial radiation therapy (SRT), which is a result of over a decade of dedicated research and development activities. Sensus has successfully incorporated the SRT therapy into its portfolio of treatment devices, the SRT-100™ and SRT-100 Vision™. To date, the SRT technology has been used to effectively and safely treat oncological and non-oncological skin conditions in thousands of patients. For more information, visit

Investor Relations:
Jeffrey Goldberger / Allison Soss
KCSA Strategic Communications
Phone: 212-896-1249 / 212-896-1267
Email: [email protected] / [email protected]

To view the original version on PR Newswire, visit:

SOURCE Sensus Healthcare, Inc.